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242Open repair versus fenestrated endovascular
aneurysm repair of juxtarenal aneurysms
Rohini Rao, BSc, Tristan R. A. Lane, MRCS, Ian J. Franklin, FRCS(Gen Surg), and
Alun H. Davies, DM, FRCS, London, United Kingdom
Background: Open repair is the gold standard management for juxtarenal aneurysms. Fenestrated endovascular aneurysm
repair (FEVAR) is indicated for high-risk patients. The long-term outcomes of FEVAR are largely unknown, and there is
no Level I comparative evidence. This systematic review and meta-analysis of case series compares elective juxtarenal
aneurysm surgery by open repair and FEVAR.
Methods: A systematic literature search was conducted for all published studies on elective repair of juxtarenal aneurysms by
FEVAR and open repair. TheMEDLINE, EMBASE, and Cochrane databases were searched from 1947 to April 2013. The
exclusion criteria were case series of <10 patients or ruptured aneurysms. The primary outcomeswere perioperativemortality
and postoperative renal insufﬁciency. The secondary outcomes were secondary reinterventions and long-term survival.
Results: We identiﬁed 35 case series with data on 2326 patients. Perioperative mortality was 4.1% in open repair and
FEVAR case series (odds ratio for open repair with FEVAR, 1.059; 95% conﬁdence interval, 0.642-1.747; P [ .822).
Postoperative renal insufﬁciency was not signiﬁcantly different (odds ratio for open repair with FEVAR, 1.136; 95%
conﬁdence interval, 0.754-1.713; P [ .542). FEVAR patients had higher rates of secondary reintervention, renal
impairment during follow-up, and a lower long-term survival compared with open repair patients.
Conclusions: FEVAR and open repair have similar short-term outcomes but have diverging long-term outcomes that may
be secondary to the selection bias of FEVAR being offered to high-risk patients. FEVAR is a favorable option in high-risk
patients, and open repair remains viable as the gold standard. (J Vasc Surg 2015;61:242-55.)Juxtarenal abdominal aortic aneurysms are deﬁned as
aneurysms with an infrarenal short proximal neck of
<15 mm that require suprarenal cross-clamping during
open repair.1 Open surgical repair of juxtarenal aneurysms
has been evolving and improving during the last 50 years
by addressing the issue of renal ischemia from suprarenal
cross-clamping through renal protection methods such as
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established long-term graft durability.2
However, this procedure is still associated with blood
loss and prolonged in-hospital recovery as well as cardiac
and pulmonary events, anastomotic bleeding, limb and renal
ischemia, and cerebrovascular events.6 Furthermore, with
an aging population and an increasing prevalence of comor-
bidities that serve as contraindications for open repair, clini-
cians and patients are seeking to increase the availability and
use of minimally invasive endovascular procedures.
Endovascular aneurysm repair (EVAR) is in widespread
use for infrarenal aneurysms and involves placing a fabric-
covered metal stent graft, under ﬂuoroscopic guidance,
intraluminally into the abdominal aorta, usually through
the femoral arteries. The endograft often has multiple com-
ponents that are assembled in vivo, and the procedure usu-
ally results in a bifurcated “inverted Y” graft inserted
distally in both the common iliac arteries and ﬁxed proxi-
mally just above the neck of the aneurysm to achieve a sta-
ble graft seal between the nonaneurysmal aorta and the
endograft.7 However, juxtarenal aneurysms are short-
necked and thus do not have a sufﬁcient length of infrare-
nal aorta to achieve a good graft seal with minimal risks of
endoleak or graft migration, and hence are not suitable for
EVAR. Furthermore, there is a risk that the endograft
could occlude the renal arteries.8
Fig 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram.
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endograft intended for short-necked aneurysms where the
proximal seal lies above the renal or visceral arteries to
achieve a sufﬁcient attachment length and graft ﬁxation
and alignment.9 These endografts incorporate fenestra-
tions, or holes in the sides of the endograft, to maintain
arterial ﬂow to the aortic branches covered by the stent
graft. These openings are carefully aligned with the renal
and visceral artery ostia in vivo, thereby allowing the prox-
imal sealing zone of the graft to extend to a region of
normal aorta located above the renal arteries without
occluding the branching arteries. FEVAR is currently
largely indicated for patients with juxtarenal aneurysms
that are unsuitable for open repair due to their high surgical
risk.10 Many centers advocate FEVAR as a viable alterna-
tive to open repair of juxtarenal aneurysms.9
Studies comparing FEVAR with open repair of juxtare-
nal aneurysms have found a signiﬁcantly lower 30-day mor-
tality rate for FEVAR compared with open repair.11,12
Whether FEVAR or open repair is superior in the long-
term is still largely unknown. Because the procedure istechnically challenging and requires advanced skills in
endovascular manipulation, it is limited to high-volume
specialist centers.1
However, because the apparent greater short-term
beneﬁts of endovascular surgery cannot be denied, there
is a high level of uncertainty in the vascular community
regarding whether FEVAR or open repair is the more
effective and safe management option for the narrow selec-
tion criteria of patients with juxtarenal aneurysms.
This systematic review aims to compare the short-term
and long-term outcomes in published case series during the
past 20 years of juxtarenal aneurysms treated by open repair
and FEVAR. These results can determine whether there is
a need to gain randomized controlled trial evidence of
open repair vs FEVAR to answer the question of which is
the most effective management strategy to improve patient
outcomes and wellbeing.
METHODS
Search strategy. Two independent observers per-
formed an Internet-based systematic literature search of
Table I. Patient demographics of all open repair case series included
Study
Year
published Country
Patients,
No.
Mean
age, years
Mean
aneurysm
diameter, cm
Males,
No. (%)
Preoperative
mean serum
creatinine,a
mmol/L
Preoperative
renal dysfunction
rate, No. (% of
patients)
Dubois19 2013 Canada 169 72.4 6.8 128 (75.7) 102.0 12 (7)
Donas10 2012 Germany 31 71.2 6.0 27 (87) 97.2 2 (6)
Tsai2 2012 USA 199 74.0 142 (71) 39 (20)
Totsugawa20 2010 Japan 26b
Speziale21 2010 Italy 92 71.5 5.3 86 (94) 122.9 36 (39)
Marrocco-Trischitta22 2009 Italy 32 70.4 5.9 28 (88) 100.8
Chisci16 2009 Italy/Sweden 61 67.8 6.3 55 (89) 6 (10)
Mukherjee23 2008 USA 56 69.0 Median, 5.7 45 (80)
Knott3 2008 USA 126 73.6 6.3 98 (78) 22 (17)
Yeung24 2008 Netherlands 23 70.0 6.7 18 (78) 146.7 12 (52)c
Pearce25 2007 USA 134 71.0 5.9 99 (74) 106.1 36 (27)
Back26 2005 USA 78d
Ryan27 2004 USA 58
Kudo28 2004 Japan 18
Bicknell29 2003 UK 44 Median, 70.0 37 (84) Median, 113
Shortell30 2003 USA 112 72.1 6.2 87 (78) 14 (12)
Sarac5 2002 USA 138 71.7 6.4 92 (67) 27 (20)
Ayari31 2001 France 53 Median, 69.0 Median, 6.0 51 (96) 21 (40)
Giulini32 2000 Italy 56 Median, 67.0 Median, 6.0 51 (91) 4 (7)
Allen33 1993 USA 31e
Poulias34 1992 Greece 38 Median, 66.0 38 (100) 6 (16)
Pooled proportion Total 1575 70.9 6.1 1082 (82) 110.7 237 (19)
aPreoperative mean serum creatinine values were converted from mg/dL to mmol/L where required.
bExcluding four cases of ruptured aneurysms.
cPreoperative serum creatinine >1.25 mg/dL.
dExcluding other visceral aneurysms.
eExcluding suprarenal and ruptured aneurysms.
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lege London Library staff. The medical databases searched
were OVID MEDLINE In-Process & Other Non-Indexed
citations, and OVID MEDLINE from 1946 to April 7,
2013. EMBASE classic and EMBASE were searched from
1947 to April 11, 2013. The Cochrane Library was searched
on April 30, 2013. A combination of the following search
terms was used: “juxtarenal aneurysm,” “open repair,”
“fenestrated endograft,” and “fenestrated graft.”
Also conducted was a search of PubMed using the
following Medical Subject Heading terms: Abdominal
Aortic Aneurysms, Vascular Surgical Procedure, Blood
Vessel Prostheses, Vascular Prosthesis Implantation, Endo-
vascular Procedure, Stent and Endoleaks.
Hand searching of relevant past reviews and confer-
ences was also done. Where information on the outcomes
of elective juxtarenal repair was not available exclusively,
or in the case of conference presentations, with no papers
published, authors were contacted for unpublished data.
Two authors conducted the literature searches indepen-
dently using the same search terms with the same databases
and then discussed together which studies ﬁt the inclusion
criteria to produce the ﬁnal list of studies.
Inclusion criteria. Cohort studies or case series con-
taining at least 10 patients, published after 1990 in English,
were included. Any studies describing patients treated for
elective open repair of juxtarenal aneurysms were consid-
ered. The term “juxtarenal aneurysm” was sufﬁcient towarrant inclusion, without the requirement of a speciﬁc
anatomic deﬁnition. No exclusion criteria were based on
the operative technique of open repair (eg, certain renal
protection measures).
Studies describing elective FEVAR of juxtarenal aneu-
rysms using all currently licensed stent grafts were included.
The literature search resulted in the inclusion of studies that
used the Zenith Fenestrated AAA Endovascular Graft
(CookMedical, Bloomington, Ind). This graft incorporates
two fenestrations for the renal artery ostia and a scallop with
a covered stent for the superior mesenteric artery. The
FEVAR patients included in the review were all treated
with purely fenestrated devices without branched/fenes-
trated device combinations.
Exclusion criteria. Studies of complex aneurysms
(pararenal and type IV thoracoabdominal) and ruptured
aneurysms were excluded, unless the author could provide
unpublished data for elective juxtarenal aneurysms only.
Patients treated with endografts other than custom-made
fenestrated stent grafts, such as hybrid repairs, branched
endografts, chimney grafts, snorkel, and endowedge tech-
niques, were excluded. Registry data were not included due
to duplicate publication.
Outcomes. The primary outcomes were perioperative
mortality (30-day and in-hospital mortality), postoperative
renal insufﬁciency (based on the study deﬁnition of renal
insufﬁciency), postoperative permanent dialysis, and renal
failure development during follow-up (persistent renal
Table II. Patient demographics of all fenestrated endovascular aneurysm repair (FEVAR) case series included
Study
Year
published Country
Patients,
No.
Mean
age, years
Mean
aneurysm
diameter, cm
Males,
No. (%)
Preoperative
creatinine
mean,a
mmoll/L
Preoperative
renal dysfunction
rate, No. (% of
patients)
Donas10 2012 Germany 29 73.7 6.5 29 (100) 106.1 5 (17)
Constantinou35,b 2012 UK 64 53 (83) 19 (30)
Metcalfe36,c 2012 UK 24 70.5 6.5 23 (96) 99
Coscas37 2012 France 38 74 5.8 34 (89) 3 (8)
Verhoeven38 2010 Netherlands/Germany 100 72.6 Median, 6.0 87 (87) 46 (46)
Mastracci39 2010 USA 150 75.1 6.6 127 (85) 107.3 33 (22)
Chisci16 2009 Italy/Sweden 52 71.5 6 42 (81) 12 (23)
Beck40 2009 Netherlands 18 72.4 16 (89) 1 (6)
Greenberg41 2009 USA/Japan 30 75 6.1 24 (80) 2 (7)
Kristmundsson42 2009 Sweden 54 Median, 72.0 Median, 6.0 46 (85) 24 (44)
Scurr43 2007 UK 45 Median, 73.0 Median, 6.8 41 (91) 6 (13)
Semmens44 2006 Australia 58 75.5 51 (88)
Halak45 2006 Australia 17
Haddad46 2005 USA 72 75 6.2 97.2 23 (32)
Pooled proportion Total 751 73.2 6 573 (86) 103.3 129 (21)
aPreoperative mean creatinine values were converted from mg/dL to mmol/L where required.
bIncluding patients with temporary axillobifemoral bypass grafting.
cUnpublished data.
Table III. Comorbidity rates in open repair and
fenestrated endovascular aneurysm repair (FEVAR)
studies
Preoperative comorbidity Open repair FEVAR Pa
Mean creatinine, mmol/L 105.8 100.9 <.0001
Rate of
Renal insufﬁciency, % 19 21.4 <.0001
Cardiac dysfunction, % 43.3 52.2 .03
Respiratory insufﬁciency, % 28.9 33.7 .01
Diabetes, % 11.8 17.4 .001
Hypertension, % 78.8 76.8 .02
aP values were calculated by the Fisher Z test for signiﬁcance.
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follow-up). The secondary outcomes included major
postoperative complications, secondary reintervention rates
during follow-up, and long-term survival (Kaplan-Meier
data). Independent outcomes for FEVAR included target
vessel patency and endoleak rates.
Heterogeneity. The open repair and FEVAR cohorts
were assessed for statistical heterogeneity in perioperative
mortality using the c2 Cochran Q statistic to determine
the validity of performing a meta-analysis of outcomes.
Statistical analysis. The rates of each outcome (eg,
perioperative mortality, postoperative renal insufﬁciency)
were calculated for each study and compared among studies
by a meta-analysis of proportions with a random effects
model. The pooled event rate in the open repair studies was
compared with the pooled event rate in the FEVAR studies
to calculate an odds ratio comparing the odds of an outcome
occurring in open repair studies vs FEVAR studies. For
continuous variables (eg, patient age, mean preoperative
serum creatinine), where studies had provided a median
value and range, the mean and standard deviation wereestimated using a formula by Hozo et al13 to pool the re-
sults. All data analysis was performed on Comprehensive
Meta-analysis 2 software (Biostat, Englewood, NJ).
For studies where Kaplan-Meier data were available (sur-
vival curves and numbers at risk), the number of deaths at
different time intervals in each individual study was calcu-
lated using the Parmar technique for summary statistic
extraction.14 The curves were then reproduced on a
single graph. For the purpose of testing the difference in
long-term survival between open repair and FEVAR, the
number of deaths and numbers at risk in all open repair
and all FEVAR studies were pooled. These data were
then used to produce a hypothetical Kaplan-Meier graph
with two survival curves (open repair vs FEVAR) using
SPSS software (IBM Corp, Armonk, NY). A log-rank
(Mantel-Cox) test for a signiﬁcant difference in survival
between the two groups was calculated.15
RESULTS
We identiﬁed 33 relevant studies from 1296 articles.
The inclusion and exclusion criteria are outlined in the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) diagram (Fig 1).
From these 33 studies, 31 were case series and two
were cohort studies.10,16 The two cohort studies were split
into four independent case series (two open repair and two
FEVAR) for the purpose of comparison and meta-analysis
with the other case series. Thus, a total of 35 case series
were included in the ﬁnal analysis: 21 case series of open
repair and 14 case series of FEVAR.
Interobserver agreement
The k statistic for interobserver agreement for inclusion
or exclusion into the study was 0.47, which shows moder-
ate agreement between the two authors.17
Fig 2. Forest plot shows the mortality rate per study with 95% conﬁdence intervals (CIs; horizontal lines), and pooled
mortality rate (represented by a diamond) for all open repair (OR) and all fenestrated endovascular aneurysm repair
(FEVAR) case series combined. The odds ratio favors FEVAR but is not signiﬁcant.
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The included studies were assessed using a validated qual-
ity of observational studies checklist (Appendix, online
only).18 The checklist was amended with certain parameters
relevant to this study, and nonrelevant items were removed.
The items of the checklist are binary data, with 0 representing
absence of the information and 1 representing presence of the
information in the study. The total score acts as a comparator
of the quality of the included studies. Themaximum scorewas
13 for open repair studies and 15 for FEVAR studies.
Publication bias
The Egger test showed evidence of publication bias
with P < .0001, bias ¼ 1.32, and 95% conﬁdence interval
(CI) 1.98 to 0.66 (Supplementary Fig 1, online only).
Patient characteristics
A total of 2326 patients were included, of whom 1575
underwent open repair and 751 underwent FEVAR. Pa-
tient characteristics are outlined in Tables I and II. In 16
open repair studies and 12 FEVAR studies, men made up
82% and 86% of the study population, respectively, which
was not a signiﬁcant difference (P ¼ .05). The mean agewas 71 years in the 15 open repair studies and 73 years
in the 12 FEVAR studies. The standard difference in
mean age was 4.986 years (95% CI, 4.802-5.170; P <
.0001) suggesting that FEVAR patients were signiﬁcantly
older than open repair patients. The mean aneurysm diam-
eter was 6.1 cm in 11 open repair studies and 6.0 cm in
eight FEVAR studies.
Comorbidities
FEVAR patients had signiﬁcantly higher rates of
preoperative renal insufﬁciency, cardiac dysfunction, res-
piratory insufﬁciency, and diabetes (Table III). Howev-
er, open repair patients had a signiﬁcantly higher
preoperative mean serum creatinine levels and rates of
hypertension.
Confounding factors
Various confounding factors, such as the year of study
publication (Supplementary Fig 2, online only), the coun-
try of publication (Supplementary Fig 3, online only), the
series size (Supplementary Fig 4, online only), and the pre-
operative serum creatinine (Supplementary Fig 5, online
only) may have inﬂuenced outcomes signiﬁcantly.
Fig 3. Forest plot shows the postoperative renal insufﬁciency rate per study with 95% conﬁdence intervals
(CIs, horizontal lines), and pooled rate (represented by a diamond) for all open repair (OR) and all fenestrated
endovascular aneurysm repair (FEVAR) case series combined. The odds ratio favors FEVAR but is not signiﬁcant.
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Perioperative mortality. The pooled perioperative
mortality was 0.041 (95% CI, 0.031-0.053) or 4.1% in
21 case series of open repair and 0.041 (95% CI 0.028-
0.059) or 4.1% in 14 case series of FEVAR (Fig 2). The
odds ratio for open repair with FEVAR was 1.059 (95% CI,
0.642-1.747; P ¼ .822) and not statistically signiﬁcant.
The Cochran Q test showed low heterogeneity between
studies (Q ¼ 28.8; P ¼ .752).
Postoperative renal insufﬁciency. Postoperative renal
insufﬁciency rates were reported in 20 open repair case se-
ries and in ﬁve FEVAR studies (Fig 3). The deﬁnitions
varied between studies, but most involved the patient’s
serum creatinine rising acutely byw44 mmol/L (0.5 mg/
dL) or a certain percentage (20%-50%) above baseline, or
an absolute rise above 133 to 354 mmol/L (1.5-4 mg/dL)
before discharge. The pooled rates were 0.139 (95% CI,
0.101-0.188) or 13.9% for open repair and 0.114 (95% CI,
0.041-0.276) or 11.4% for FEVAR. The odds ratio for
open repair with FEVAR was 1.136 (95% CI, 0.754-1.713;
P ¼ .542) and not statistically signiﬁcant.
Postoperative permanent dialysis. The rates of new
permanent hemodialysis (not resolved before discharge)
were reported in 15 open repair studies and in sevenFEVAR studies (Fig 4). The pooled rates were 0.028
(95% CI, 0.017-0.044) or 2.8% for open repair and 0.019
(95% CI, 0.008-0.044) or 1.9% for FEVAR. The odds ratio
for open repair with FEVAR was 1.660 (95% CI, 0.627-
4.397; P ¼ .308) and not statistically signiﬁcant.
Renal failure during follow-up. Persistent renal
insufﬁciency at discharge or development of renal failure
during follow-up was reported in 11 of 21 open repair
studies and in six of 14 FEVAR studies (Fig 5). The pooled
event rate was 0.077 (95% CI, 0.050-0.118) or 7.7% in
open repair and was 0.197 (95% CI, 0.147-0.258) or
19.7% in FEVAR. The odds ratio for open repair with
FEVAR was 0.375 (95% CI, 0.263-0.536; P < .0001),
which was signiﬁcant in favor of open repair, indicating that
more FEVAR patients developed renal failure during
follow-up than open repair patients.
Secondary reintervention rate. Nine of 21 open
repair studies and nine of 14 FEVAR studies reported the
requirement for graft-related secondary reinterventions
during follow-up (between 0 and 120 months.) Most open
repair reinterventions were for bleeding during surgery
(Table IV), whereas those for FEVAR were for endoleak or
vessel occlusion/stenosis. The pooled event rate was 0.049
(95% CI, 0.029-0.082) or 4.9% for open repair and 0.127
(95% CI 0.090-0.117) or 12.7% for FEVAR (Fig 6). The
Fig 4. Forest plot shows the postoperative permanent hemodialysis rate per study with 95% conﬁdence intervals (CIs,
horizontal lines), and pooled rate (represented by a diamond) for all open repair (OR) and all fenestrated endovascular
aneurysm repair (FEVAR) case series combined. The odds ratio favors FEVAR but is not signiﬁcant.
Fig 5. Forest plots show the rate of renal failure over follow-up per study, with 95% conﬁdence intervals (CIs, horizontal
lines), and pooled rate (represented by a diamond) for all open repair and fenestrated endovascular aneurysm repair
(FEVAR) case series combined. The odds ratio favors open repair and is signiﬁcant.
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Table IV. Secondary reinterventions during follow-up in open repair and fenestrated endovascular aneurysm repair
(FEVAR) studies
Study Year
Details of complication requiring
secondary reintervention
Time of
reintervention
Morbidity from
reintervention
Mean
follow- up
Open repair
Donas10 2012 d Acute left popliteal artery
occlusion and rest pain treated
by popliteal vein bypass grafting
Perioperative Uneventful 24 months
Tsai2 2012 d 5 remote descending thoracic
aneurysms: 4 treated by
TEVAR and 1 by open thoracic
aortic aneurysm repair
d Infection of left aortofemoral
bypass treated by graft resection
and right femoropopliteal
bypass
1 month
postoperative
Uneventful 56 months
Speziale21 2010 d Bleeding treated by second
laparotomy
d Acute lower limb ischemia
treated by Fogarty catheter
embolectomy
Perioperative 54 months
Chisci16 2009 d Fogarty embolectomy þ iliac
stent
d 3 incisional hernia repairs
d Fogarty embolectomy þ
recanalization
d Major amputation
19.5 months
Sarac5 2002 d Bleeding treated by second
laparotomy
d Lower extremity embolic events
treated
Allen33 1993 d 2 cases of bleeding treated by
second laparotomy
Poulias34 1992 d Bleeding treated by second
laparotomy
Perioperative
FEVAR
Donas10 2012 d Symptomatic left renal artery
occlusion treated by open
thrombectomy of artery and
Dacrona ileorenal bypass
grafting
d Symptomatic superiormesenteric
artery restenosis treated by
additional stent placement
6 months Uneventful
Metcalfe36 2012 d Type II endoleak treated by
renal stent dilation
d Washout of groin wound with
sartorius ﬂap reconstruction
d Iliac limb occlusion treated by
femorofemoral crossover graft
d Kinked iliac limb treated by self-
expanding stent implantation
4-6 months,
12 months
13 months
Verhoeven38 2010 d Suspected mesenteric ischemia
treated by laparotomy, bypass
right renal artery and stent graft
pull down by laparotomy
d Iliac stenosis treated by stenting
d Late renal artery occlusion
in 2 patients treated by
catheterization
d Persistent inferior mesenteric
artery thrombosis treated by
coil embolization
d Persistent lumbar arteries
treated by laparotomy
d Iliac limb occlusion treated by
cross-over bypass
Perioperative,
30 days,
2 months-18
months
d Failed catheterizations of
severe renal artery stenosis
at 2 and 18 months
resulting in renal artery
occlusion
d Failed renal artery
catheterization at
13 months
d Cross-over bypass
disconnect between tube
and bifurcation treated by
thoracic stent graft at
20 months
24 months
Beck40 2009 None 23 months
(Continued on next page)
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Table IV. Continued.
Study Year
Details of complication requiring
secondary reintervention
Time of
reintervention
Morbidity from
reintervention
Mean
follow- up
Greenberg41 2009 d 3 patients treated by angioplasty
at 6, 12, and 24 months for
in-stent stenosis of right renal
artery; 1 patient treated for
bilateral renal artery in-stent
stenosis at 6 months.
d Left renal artery occlusion
treated by left iliac-renal bypass
6, 12, 24 months Uneventful 24 months
Chisci16 2009 d Fogarty embolectomy þ
ﬁbrinolysis
d Major amputation
d Fogarty embolectomy þ
ﬁbrinolysis
d Stent graft þ coil embolization
of superﬁcial femoral artery
d Renal artery stent graft
d Superior mesenteric artery stent
19.5 months
Kristmundsson42 2009 d Distal type I endoleak treated
by Giant Palmazb stent in right
iliac artery
d Type II endoleak treated by coil
embolization of inferior
mesenteric artery and glue
embolization of lumbar arteries
d Renal artery stenoses treated by
percutaneous transluminal
angioplasty at 12 months.
Perioperative,
1-18 months
25 months
Scurr43 2007 d Distraction of graft components
treated by bridging cuff
addition at 28 months
d 2 iliac limb extensions at 1 and
24 months
d Progressive stenotic disease
treated by iliac angioplasty at
6 months
d Stenosis within stented superior
mesenteric artery treated by
angioplasty at 15 days
Perioperative,
1 month,
28 months
d Patient with distraction of
graft components later
died of pancreatitis
d Patient with superior
mesenteric artery stenosis
developed critical stenosis
at 6 months, which was
successfully treated by
iliac-superior mesenteric
artery bypass.
24 months
Semmens44 2006 d Unresolved type I endoleak
treated by Giant Palmaz Stent
d Persistent type II endoleaks
treated by coil embolization
and laparotomy
d Distal component graft
migration downwards treated
by bridge reinforcement
d Distal extension to right
external iliac artery treated by
coil occlusion
d Debridement and resuture of
wound
Perioperative,
16.8 months
d 2 patients died #30 days
of secondary procedure
d 1 patient died after
secondary procedure
(performed 2 years after
primary procedure)
16.8 months
TEVAR, Thoracic aortic aneurysm repair.
aCordis, Miami Lakes, Fla.
bDuPont, Wilmington, Del.
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0.212-0.525; P < .0001), which was signiﬁcant in favor
of open repair, suggesting that FEVAR patients have to
undergo a greater number of repeat procedures during
follow-up.
Major complications. Open repair studies had a
signiﬁcantly higher postoperative major complication ratecompared with FEVAR (25.0% vs 15.7%; P ¼ .001). These
included cardiac events (myocardial infarction, arrhyth-
mias), pulmonary infections, ischemic colitis, pulmonary
embolism, and wound complications.
Long-term survival. Only two open repair studies
and ﬁve FEVAR studies provided Kaplan-Meier curves
with numbers at risk. The survival data for open repair
Fig 6. Forest plot shows the secondary intervention rate per study with 95% conﬁdence intervals (CIs, horizontal lines),
and pooled rate (represented by a diamond) for all open repair (OR) and all fenestrated endovascular aneurysm repair
(FEVAR) case series combined. The odds ratio favors open repair and is signiﬁcant.
Fig 7. Hypothetical estimated Kaplan-Meier survival curves
(pooled) of all patients combined from two open repair studies
(Ayari,31 2001 and Knott3 2008) and ﬁve fenestrated endovascular
aneurysm repair (FEVAR) studies (Beck,40 2009; Kristmundsson,42
2009; Mastracci,39 2010; Verhoeven,38 2010; and Metcalfe,36
2012).
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pothetical Kaplan-Meier curves that were compared by a
log-rank (Mantel-Cox) test for signiﬁcance (Fig 7).
FEVAR had a signiﬁcantly lower long-term survival than
open repair (P ¼ .09) with 93%, 74%, and 55% survival
at 1, 3 and 5 years, respectively; whereas open repair
had 89%, 80%, and 73% survival at 1, 3, and 5 years,
respectively.
Outcomes for FEVAR
Target vessel patency. Target vessel patency is an
important measure of long-term graft resilience and likeli-
hood of survival. The case series reported in Table V had a
pooled vessel patency of 98.2% at completion angiography.
In the long-term (5 years), the studies reported a 95.8%
patency during follow-up.
Endoleak. The rates of early types I and III endoleak
were 5.8% and 2.6%, respectively, and rates of late endo-
leaks were 2.2% and 3.2% (Table VI).
DISCUSSION
This systematic review demonstrates that open repair
and FEVAR of juxtarenal aneurysms have an equivalent
safety proﬁle in perioperative mortality and early postoper-
ative renal impairment. FEVAR has been shown to portray
the beneﬁts of minimally invasive surgery with lower rates
of infection and bleeding. In addition, this review has
highlighted low rates of endoleak and high rates of target
vessel preservation after FEVAR, which are a testament
to excellent technical application, and it provides a usefuloption for clinicians whose patients are unﬁt for open
repair.
The FEVAR cohort had an increased progression to
renal impairment during follow-up, higher secondary
Table V. Target vessel patency in fenestrated
endovascular aneurysm repair (FEVAR) case series at
completion angiography and during follow-up
Study Year
Target vessel patency
At completion
angiography, No. (%)
During follow-up,
No. (%)
Donas10 2012 43/44
Constantinou35 2012 159/161
Metcalfe36,a 2012 42/42
Verhoeven38 2010 272/275 263/275
Beck40 2009 56/56 53/56
Greenberg41 2009 77/77
Kristmundsson42 2009 131/134 129/134
Scurr43 2007 82/82 79/82
Halak45 2006 35/35
Semmens44 2006 105/116
Haddad46 2005 141/142
Total target
vessel patency
1143/1164 (98.2) 524/547 (95.8)
aUnpublished data.
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be attributable to higher rates of preoperative comorbidity;
however, deﬁnitive evidence of this would require a ran-
domized controlled trial or cohort study with matched pa-
tients and long-term follow-up of 5 to 10 years, which may
be unfeasible. FEVAR presents other factors that may
contribute to this progressive renal damage, including
contrast load from lifelong computed tomography (CT)
surveillance.47 Because FEVAR showed excellent target
vessel patency rates in this study, target vessel occlusion is
unlikely to be a cause of the increased rate of renal failure
in the long-term.
The FEVAR patients were on average 5 years older
than those undergoing open repair, with higher rates of
preoperative renal impairment, diabetes, cardiovascular dis-
ease, and respiratory insufﬁciency; therefore, the worsened
outcomes for mortality and development of renal insufﬁ-
ciency may be expected. There is, however, signiﬁcant
clinical and methodologic heterogeneity among the
studies, and this may confound the interpretation of these
outcomes.
Varied deﬁnitions of preoperative and postoperative
renal impairment were used and not always based on an ab-
solute value of serum creatinine. This inconsistency may
explain the discrepancy found that open repair patients
had a higher mean preoperative serum creatinine than
FEVAR patients; however, the pooled preoperative renal
insufﬁciency rate (based on study deﬁnition) was higher
among FEVAR patients. Consistent reporting among
studies and the use of standardized assessment of renal
impairment in the future is needed to avoid confounding re-
sults. Other confounding factors that may have an inﬂuence
on improved outcomes are highlighted by meta-regression
analysis (Supplementary Figs 2-5), and include more recent
studies, studies that took place in countries such as the
United States, Japan, Italy, or the Netherlands, increasing
study size, and lower preoperative serum creatinine.The perioperative mortality rates in open repair and
FEVAR studies were exemplary and equivalent (4.1%),
despite a higher rate of postoperative major complications
with open repair (P ¼ .001) and reinterventions due to
bleeding and embolic events. Jongkind et al48 found a
2.9% rate for pooled perioperative mortality after elective
open juxtarenal repair, and Nordon et al11 reported 3.6%
in their systematic review. These low mortality rates may
be attributable to improvements in renal and visceral pro-
tective strategies during open repair (cold perfusion and
mannitol).12
The improved 5-year survival rates seen with open
repair (73% vs 55%) may be secondary to selection bias,
with higher-risk patients offered FEVAR; alternatively,
with secondary reintervention rates of FEVAR signiﬁcantly
higher than in open repair, such reintervention may ac-
count for the decreased long-term survival. Most of the
reinterventions for FEVAR occurred between 6 and
12 months postoperatively, whereas those required in
open repair were in the short-term (#30 days), which
puts into question the durability of FEVAR (Table IV).
Whereas most patients with secondary reinterventions
in the open repair group had uneventful recoveries, some
cases of reintervention from FEVAR led to signiﬁcant
morbidity and mortality. These cases were due to distrac-
tion of graft components, endoleaks, graft kinking, and
renal artery occlusion leading to failed catheterizations
and death #30 days of reintervention. This would be
consistent with the increased risk of aneurysm rupture
from endoleaks, graft migration, and kinking seen in
EVAR.49 However, considering the excellent target vessel
patency rates and low endoleak rates seen in this review,
as well as the literature ﬁndings of very low graft migration
rates of between 1.5% and 4.2%,50,51 the effect of graft
durability on survival appears complex.
With respect to the development of renal failure in the
long-term, although limited by heterogenous reporting of
renal outcomes, this study indicates that FEVAR patients
do not risk signiﬁcantly higher rates of immediate postop-
erative renal dysfunction due to procedurally induced athe-
roemboli. The higher rates of progression to renal
impairment are likely secondary to worse baseline renal
function. However, our ﬁndings lend weight to the sugges-
tion that as FEVAR patients undergo CT angiography sur-
veillance at short intervals, contrast nephropathy is also a
likely signiﬁcant contributor to the development of long-
term renal impairment.47 This should encourage the devel-
opment and practice of ultrasound follow-up for FEVAR
patients as for EVAR.52 Greenberg et al53 hypothesize
that delayed renal impairment in the FEVAR group may
be due to contrast-induced nephropathy, delayed deposi-
tion of emboli triggered during the procedure, and renal
damage from suprarenal stent ﬁxation. This may also
explain the increased progression to renal impairment dur-
ing follow-up with FEVAR in this study.
The main limitation of this study is the reporting bias
of the studies, which showed a lack of information on the
operative experience of the surgeon or the volume of
Table VI. Endoleak rates in fenestrated endovascular aneurysm repair (FEVAR) case series at completion angiography
within the ﬁrst 6 months after surgery and after 6 months
Study Year
Endoleaks at completion angiography Early endoleaks (#6 months) Late endoleaks (>6 months)
Type I,
No. (%)
Type II,
No. (%)
Type III,
No. (%)
Type I,
No. (%)
Type II,
No. (%)
Type III,
No. (%)
Type I,
No. (%)
Type II,
No. (%)
Type III,
No. (%)
Donas10 2012 1 (3.4)
Coscas37 2012 2 (5.3) 2 (5.3) 1 (2.6) 6 (15.8) 7 (18.4) 1 (2.6) 1 (2.6) 4 (10.5) 1 (2.6)
Metcalfe36 2012 3 (12.5) 3 (12.5) 1 (4.2) 2 (8.3) 1 (4.2)
Greenberg41 2009 8 (26.7) 6 (20.0) 4 (13.3)
Kristmundsson42 2009 3 (5.6) 13 (24.1) 1 (1.9) 3 (5.6)
Chisci16 2009 2 (3.8) 1 (1.9) 13 (25.0)
Scurr43 2007 4 (8.9)
Semmens44 2006 4 (6.9) 2 (3.4)
Halak45 2006 0 (0.0)
Total endoleak rate, % 5.8 12.9 2.6 15.8 14.4 2.6 2.2 13.1 3.2
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more robust comparison of open repair and FEVAR.
Also lacking is follow-up and long-term outcomes informa-
tion and target vessel patency for open repair studies. There
was a lack of follow-up data on the rates of graft thrombosis
and stenosis in the open repair studies, which prevented
analysis and comparison with long-term graft durability
data in the FEVAR group. Furthermore, FEVAR had
more variable outcomes than open repair, which may be
attributable to the heterogeneity of this complex procedure
involving intricate and signiﬁcant endovascular manipula-
tion, or the relative youth of the procedure that confounds
the validity of outcomes. The systematic literature search
did not include potentially valuable sources of data due
to duplicate publications.54
From the study quality assessment, it was clear that low-
scoring studies failed to provide clear inclusion and exclu-
sion criteria, did not report fully the statistical parameters
required for a meta-analysis (eg, standard deviation), and
did not report long-term outcomes. The heterogenous def-
initions of renal insufﬁciency and juxtarenal aneurysmsmade
the accurate and valid assimilation of the data difﬁcult.
In the future, surgeons may wish to focus on continuing
to improve endovascular techniques to improve the long-
term durability and reduce the rate of reinterventions and
their consequent morbidity. All stent grafts described in
this study were Cook Zenith endografts. These stents are
bespoke for each patient, taking 4 to 6 weeks to manufac-
ture, with high expense. Multiple other devices are now
available, and off-the-shelf fenestrated grafts are being eval-
uated for juxtarenal aneurysms, which should reduce costs
for FEVAR treatments and might alter the balance of
preferred treatments.55
A randomized controlled trial comparing open repair
with FEVAR would provide Level 1 evidence to guide clini-
cians in the future, based on this study’s ﬁndings that open
repair appears to be safe in appropriate patients and durable,
with good long-term outcomes, whereas FEVAR has shown
a similar efﬁcacy to open repair and appears to be a safe and
valid option for high-risk patients who are unsuitable foropen repair. A comparative study would require consider-
able numbers to investigate further the small, nonsigniﬁcant
differences in procedural safety seen in this analysis.
CONCLUSIONS
Overall, open repair and FEVAR can both be used
safely and with low postoperative morbidity and mortality
in the short-term. The concerns of suprarenal cross-
clamping and periprocedural atheroemboli causing high
rates of postoperative renal impairment in both open repair
and FEVAR, respectively, are not supported by the evi-
dence, with both offering similar and low rates of postop-
erative renal impairment. However, FEVAR has a higher
rate of progression to renal impairment during follow-up,
a greater rate of secondary reinterventions, and a lower
long-term survival, which may be partly attributed to
FEVAR currently being performed on high-risk patients
but may also be due to perioperative contrast use and
recurrent contrast CT surveillance. FEVAR has shown
excellent outcomes for high-risk patients, and continued
improvements in technique and devices to lower the
requirement for secondary reinterventions may, in the
future, encourage a FEVAR ﬁrst strategy in anatomically
feasible patients.
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Supplementary Fig 1 (online only). Egger funnel plot displays
publication bias. The funnel plot shows the perioperative mortality
rate on a logarithmic scale against the standard error for each study
in the meta-analysis. The vertical line with the diamond shows the
pooled estimate of the logit perioperative mortality rate in all of the
studies, and the diagonal lines show the 95% conﬁdence interval
(CI) for a given standard error.
Supplementary Fig 2 (online only). Meta-regression shows the relationship between the year of study publication
and the logit perioperative mortality rate of the studies.
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Supplementary Fig 3 (online only). Chart outlines the periop-
erative mortality rates based on country of study publication. The
various symbols, including triangles, crosses, and squares, represent
individual studies. FEVAR, Fenestrated endovascular aneurysm
repair.
Supplementary Fig 4 (online only). Meta-regression shows the relationship between study size and the logit
perioperative mortality rate of the studies. FEVAR, Fenestrated endovascular aneurysm repair.
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Supplementary Fig 5 (online only). Meta-regression shows the relationship between mean preoperative creatinine of
the patients included in the studies and the logit perioperative mortality rate of the studies.
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Appendix (online only). Study quality assessment of 21 open repair case seriesa
Author Year Study type
Hypothesis/
aim
Main
outcomes
Inclusion/
exclusion
criteria clearly
described
Interventions
clearly
described
Clear deﬁnitions
Juxtarenal
aneurysm
Renal
failure
Pearce25 2007 Case series 1 1 1 1 1 1
Knott3 2008 Case series 1 1 1 1 1 1
Ayari31 2001 Case series 1 1 0 1 1 1
Dubois19 2013 Case series 1 1 1 1 1 1
Tsai2 2012 Case series 1 1 1 1 0 1
Speziale21 2010 Case series 1 1 1 1 0 1
Chisci16 2009 Case control 1 1 1 1 0 1
Back26 2005 Case series 1 0 1 1 1 1
Shortell30 2003 Case series 1 1 1 1 1 1
Sarac5 2002 Case series 1 1 1 1 1 1
Allen33 1993 Case series 1 0 1 1 1 1
Donas10 2012 Case control 1 1 1 1 1 1
Totsugawa20 2010 Case series 1 1 1 1 1 0
Marrocco-Trischitta22 2009 Case series 1 1 0 1 1 1
Bicknell29 2003 Case series 1 1 1 1 1 1
Kudo28 2004 Case series 1 0 1 1 1 1
Giulini32 2000 Case series 1 0 0 1 0 1
Yeung24 2008 Case series 1 0 1 1 0 1
Mukherjee23 2008 Case series 0 0 0 1 0 0
Ryan27 2004 Case series 0 0 1 1 0 1
Poulias34 1992 Case series 0 0 0 1 1 0
Table adapted from Downs and Black18 (1998).
aA score of 1 indicates the presence of a parameter, and 0 indicates absence of the parameter. The maximum score for each open repair study is 13 if all the
parameters of the checklist scale are present.
Appendix (online only). Study quality assessment of 14 fenestrated endovascular aneurysm repair (FEVAR) case seriesa
Author Year Study type
Hypothesis/
aim
Main
outcomes
Inclusion/exclusion
criteria clearly
described
Interventions
clearly
described
Clear
deﬁnitions
Main
ﬁndings
described
Juxtarenal
aneurysm
Renal
failure
Verhoeven38 2010 Case series 1 1 1 1 1 1 1
Metcalfe36 2012 Case series 1 1 1 1 0 1 1
Greenberg41 2009 Case series 1 1 1 1 0 1 1
Kristmundsson42 2009 Case series 1 1 1 1 0 1 1
Scurr43 2008 Case series 1 1 0 1 1 1 1
Beck40 2009 Case series 1 0 1 1 0 0 1
Semmens44 2006 Case series 1 1 1 1 0 1 1
Mastracci39 2010 Case series 1 1 1 1 0 0 1
Coscas37 2012 Case series 1 1 0 1 0 1 1
Constantinou35 2012 Case series 1 1 0 1 0 0 1
Halak45 2006 Case series 1 1 0 1 1 0 1
Table adapted from Downs and Black18 (1998).
a1 indicates the presence of a parameter, and 0 indicates absence of the parameter. The maximum score for each FEVAR study is 15 if all the parameters of the
checklist scale are present.
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Appendix (online only). Continued.
Main
ﬁndings
described
Range of values for
outcomes outlined
(eg standard error)
All important
adverse events
reported
Survival
analysis
conducted
Appropriate
statistical
tests
Valid and
reliable outcome
measures used
Losses to
follow up
taken into
account
Total
score (/13)
1 1 1 1 1 1 1 13
1 1 1 1 1 1 0 12
1 1 1 1 1 1 1 12
1 1 1 0 1 1 0 11
1 1 1 1 1 1 0 11
1 1 1 1 1 1 0 11
1 1 1 1 1 1 0 11
1 1 1 1 1 1 0 11
1 1 1 0 1 1 0 11
1 1 1 0 1 1 0 11
1 1 1 0 1 1 1 11
1 1 0 0 1 1 0 10
1 1 1 0 1 1 0 10
1 1 1 0 1 1 0 10
1 1 0 0 1 1 0 10
1 1 0 0 1 1 0 9
1 1 1 0 1 1 0 8
1 0 0 0 1 1 0 7
1 1 1 0 1 1 0 6
1 0 0 0 0 1 0 5
1 0 1 0 0 1 0 5
Appendix (online only). Continued.
Range of values for
outcomes outlined
(eg standard error)
All important
adverse events
reported
Survival
analysis
conducted
Appropriate
statistical
tests
Valid and
reliable
outcomes
Loss to follow
up taken
into account
Endoleak and
reintervention rates reported
Total
score
(/15)
Endoleak
rate
Reintervention
rate
1 1 1 1 1 1 1 1 15
1 1 1 1 1 1 1 1 14
1 1 1 1 1 1 1 1 14
1 0 1 1 1 1 1 1 13
1 1 0 1 1 0 1 1 12
1 1 1 1 1 1 0 1 11
1 0 0 1 1 0 1 1 11
1 0 1 1 1 1 0 0 10
1 0 1 1 1 0 0 0 9
1 1 0 1 1 0 0 0 8
1 0 0 0 1 0 1 0 8
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